FRI0148 IS TREATMENT ADHERENCE OF RA PATIENTS TO MTX IMPROVED BY THE SWITCH FROM ORAL TO SUBCUTANEOUS ABMINISTRATION? RESULTS FROM THE PROSPECTIVE APRIM STUDY